Management of eosinophilic granulomatosis with polyangiitis-associated sinusitis with dual biologics: Anti-interleukin-5/interleukin-5 receptor plus anti-interleukin-4/interleukin-13

Authors

S Shahzad Mustafa, Rochester Regional HealthFollow
Anthony Ocon, Rochester Regional HealthFollow
Karthik Vadamalai, Department of Medicine, Division of Critical Care Medicine, Baylor College of Medicine, Houston, Texas; Department of Medicine, Division of Critical Care Medicine, University of Houston Tilman J. Fertitta Family College of Medicine, Houston, Texas.
Allison Ramsey, Rochester Regional HealthFollow

Department

Allergy and Immunology

Additional Department

Rheumatology

Document Type

Article

Publication Title

Annals of Allergy, Asthma & Immunology

First Page

332

Last Page

334

DOI

10.1016/j.anai.2025.06.010

Volume

135

Issue

3

Publication Date

9-1-2025

PubMed ID

40499648

Recommended Citation

Mustafa, S. S., Ocon, A., Vadamalai, K., & Ramsey, A. (2025). Management of eosinophilic granulomatosis with polyangiitis-associated sinusitis with dual biologics: Anti-interleukin-5/interleukin-5 receptor plus anti-interleukin-4/interleukin-13. Annals of Allergy, Asthma & Immunology, 135 (3), 332-334. https://doi.org/10.1016/j.anai.2025.06.010